Profile
David McMullin served as the Chief Commercial Officer at Aldeyra Therapeutics, Inc. from 2019 to 2021.
Prior to that, he was the Group Vice President-U.S.
Internal Medicine at Shire Plc from 2015 to 2017, and the VP-Global Supply Chain Operations & Strategy at Novartis Vaccines & Diagnostics, Inc. from 2010 to 2015.
McMullin received his undergraduate degree from Brigham Young University and his MBA from Harvard Business School.
Former positions of David McMullin
| Companies | Position | End |
|---|---|---|
| ALDEYRA THERAPEUTICS, INC. | Corporate Officer/Principal | 2020-12-31 |
| SHIRE | Corporate Officer/Principal | 2017-04-30 |
Novartis Vaccines & Diagnostics, Inc.
Novartis Vaccines & Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Corporate Officer/Principal | 2015-02-28 |
Training of David McMullin
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Aldeyra Therapeutics, Inc.
Aldeyra Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for eye diseases | Health Technology |
Shire Plc
Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
Brigham Young University
Brigham Young University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Vaccines & Diagnostics, Inc.
Novartis Vaccines & Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Harvard Business School
Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- David McMullin
















